PBM Psyence Biomedical Ltd. - Common Shares
PBM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
PBM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 9 filers · $1.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (+6 vs prior Q) | 0 (-3 vs prior Q) | 0 (0 vs prior Q) | 0 (0 vs prior Q) | +194K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Parallel Advisors, LLC | $574,750 | 151,250 | 49.21% | Shares |
| AdvisorShares Investments LLC | $373,883 | 122,184 | 32.01% | Shares |
| MORGAN STANLEY | $115,680 | 37,804 | 9.90% | Shares |
| XTX Topco Ltd | $46,188 | 15,094 | 3.95% | Shares |
| CITADEL ADVISORS LLC | $35,781 | 11,693 | 3.06% | Shares |
| JANE STREET GROUP, LLC | $21,071 | 6,886 | 1.80% | Shares |
| Stonehage Fleming Financial Services Holdings Ltd | $272 | 89 | 0.02% | Shares |
| UBS Group AG | $184 | 60 | 0.02% | Shares |
| Caitlin John, LLC | $107 | 35 | 0.01% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| KAOS Capital Ltd., Adam Arviv | Jan. 13, 2026 | 4.91% | Amendment | Passive investment | SEC |
| Psyence Group Inc. ×3 filings | May 12, 2025 | 0.00% | Amendment | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.